{"filing":{"accession_number":"0001213900-26-061772","cik":"0001739174","ticker":"PHGE","company_name":"BiomX Inc.","form":"8-K","filing_date":"2026-05-28","report_date":null,"primary_document":"ea0292479-8k_biomx.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026061772/ea0292479-8k_biomx.htm"},"events":[{"id":8472,"run_id":7436,"accession_number":"0001213900-26-061772","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"BiomX appointed Roy Rousso as Chief Business Officer effective July 1, 2026, with detailed compensation terms including a monthly consulting fee of $11,900, performance bonus eligibility up to 50%, and an equity award of 200,000 shares vesting over three years. This is a material executive appointment disclosing a senior officer role and significant compensatory arrangements that would affect investor assessment of the company's leadership and capital structure.","company_name":"BiomX Inc.","ticker":"PHGE","filing_date":"2026-05-28","form":"8-K","submitted_at":null,"items":[{"id":2373,"accession_number":"0001213900-26-061772","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"BiomX appointed Roy Rousso as Chief Business Officer effective July 1, 2026, with detailed compensation terms including a monthly consulting fee of $11,900, performance bonus eligibility up to 50%, and an equity award of 200,000 shares vesting over three years. This is a material executive appointment disclosing a senior officer role and significant compensatory arrangements that would affect investor assessment of the company's leadership and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:41:08.482093+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2373,"accession_number":"0001213900-26-061772","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"BiomX appointed Roy Rousso as Chief Business Officer effective July 1, 2026, with detailed compensation terms including a monthly consulting fee of $11,900, performance bonus eligibility up to 50%, and an equity award of 200,000 shares vesting over three years. This is a material executive appointment disclosing a senior officer role and significant compensatory arrangements that would affect investor assessment of the company's leadership and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:41:08.482093+00:00","company_name":"BiomX Inc.","ticker":"PHGE","filing_date":"2026-05-28"}]}